Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data

BACKGROUND: Pulmonary hypertension (PH) is a serious complication of chronic obstructive pulmonary disease (COPD). While clinical guidelines recommend specific drug therapies for pulmonary arterial hypertension (PAH), these drug therapies are not recommended for PH due to lung disease. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Tracey J., Rosen Ramey, Dena, Yang, Lingfeng, Liu, Xinyue, Patel, Mahesh J., Rajpathak, Swapnil, Bajwa, Ednan K., Lautsch, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578250/
https://www.ncbi.nlm.nih.gov/pubmed/36258171
http://dx.doi.org/10.1186/s12890-022-02167-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578250/
https://www.ncbi.nlm.nih.gov/pubmed/36258171
http://dx.doi.org/10.1186/s12890-022-02167-9

Ejemplares similares